RG
MDVL

Redmile Group’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Redmile Group’s Portfolio MDVL Stock Details MDVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-692,082
Closed -$3.05M – 83
2023
Q4 		$3.05M Hold
692,082
– – 0.11% 60
2023
Q3 		$4.19M Sell
692,082
-8
-0% -$82 0.2% 53
2023
Q2 		$8.48M Hold
692,090
– – 0.33% 51
2023
Q1 		$9.92M Hold
692,090
– – 0.43% 53
2022
Q4 		$10.4M Hold
692,090
– – 0.42% 45
2022
Q3 		$26.9M Buy
692,090
+188,235
+37% +$10.8M 1.04% 31
2022
Q2 		$38.5M Buy
503,855
+282,353
+127% +$24.8M 1.47% 22
2022
Q1 		$10.8M Hold
221,502
– – 0.34% 52
2021
Q4 		$15.5M Sell
221,502
-12,993
-6% -$1.4M 0.35% 51
2021
Q3 		$34.2M Hold
234,495
– – 0.6% 44
2021
Q2 		$144M Hold
234,495
– – 2.13% 13
2021
Q1 		$164M Hold
234,495
– – 2.31% 11
2020
Q4 		$176M Buy
+234,495
New +$164M 2.14% 12

Redmile Group's MDVL Position: Q1 2024 in Review

Redmile Group sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 692,082 shares — an estimated $3.05M sold.

Redmile Group first reported a position in MDVL in Q4 2020 and held it in 13 quarters. The position peaked at $176M in Q4 2020. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.

  • Redmile Group reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Redmile Group sold 692,082 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $3.05M.
  • Redmile Group first reported a position in MedAvail Holdings, Inc. Common Stock in Q4 2020 and held it in 13 quarters.
  • Redmile Group's MedAvail Holdings, Inc. Common Stock position peaked at $176M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.

Based on Redmile Group's 13F filing for Q1 2024, filed 15 May 2024.